{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:02:17Z","timestamp":1789603337830,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013102","name":"Shanghai City Youth Science and Technology Star Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2026.07.017","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:09:41Z","timestamp":1784128181000},"page":"5926-5943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity"],"prefix":"10.1016","volume":"16","author":[{"given":"Runqiu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-4106","authenticated-orcid":false,"given":"Yiru","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.07.017_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.07.017_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-immunol-101220-015603","article-title":"B cell function in the tumor microenvironment","volume":"40","author":"Downs-Canner","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2026.07.017_bib3","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.4049\/jimmunol.0903009","article-title":"B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice","volume":"184","author":"DiLillo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.07.017_bib4","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","article-title":"Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.017_bib5","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1016\/j.apsb.2025.09.027","article-title":"Tertiary lymphoid structures: the touchstone for tumor immunotherapy","volume":"15","author":"Zhou","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.07.017_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib9","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","article-title":"The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma","volume":"12","author":"Hao","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.07.017_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","article-title":"B-cell-specific checkpoint molecules that regulate anti-tumour immunity","volume":"619","author":"Bod","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cmet.2023.12.020","article-title":"Targeting Erbin-mitochondria axis in platelets\/megakaryocytes promotes B cell-mediated antitumor immunity","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.07.017_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.06.038","article-title":"Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.017_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0888-7543(03)00095-8","article-title":"Identification of eight genes encoding chemokine-like factor superfamily members 1\u20138 (CKLFSF1\u20138) by in silico cloning and experimental validation","volume":"81","author":"Han","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.apsb.2026.07.017_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00432-021-03835-9","article-title":"CMTM6, a potential immunotherapy target","volume":"148","author":"Liang","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.apsb.2026.07.017_bib15","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00262-022-03171-y","article-title":"CMTM6 as a master regulator of PD-L1","volume":"71","author":"Yaseen","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.apsb.2026.07.017_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216585","article-title":"CMTM6 promotes hepatocellular carcinoma progression through stabilizing beta-catenin","volume":"583","author":"Liu","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2026.07.017_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143643","article-title":"CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1\/AKT\/GSK3beta axis","volume":"6","author":"Mohapatra","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.07.017_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ccell.2023.05.014","article-title":"The CD58\u2013CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity","volume":"41","author":"Ho","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.07.017_bib21","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ccell.2023.08.008","article-title":"CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1","volume":"41","author":"Miao","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.07.017_bib22","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41401-022-01020-3","article-title":"Construction of stable membranal CMTM6-PD-L1 full-length complex to evaluate the PD-1\/PD-L1-CMTM6 interaction and develop anti-tumor anti-CMTM6 nanobody","volume":"44","author":"Jia","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2026.07.017_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1158\/2326-6066.CIR-22-0439","article-title":"Suppression of tumor or host intrinsic CMTM6 drives antitumor cytotoxicity in a PD-L1-independent manner","volume":"11","author":"Long","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.apsb.2026.07.017_bib24","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1016\/j.apsb.2025.05.005","article-title":"Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage\/NK cell-associated antitumor effects","volume":"15","author":"Hu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.07.017_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat Methods"},{"key":"10.1016\/j.apsb.2026.07.017_bib26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.017_bib27","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.4049\/jimmunol.179.7.4473","article-title":"Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B","volume":"179","author":"Qiao","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.07.017_bib28","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.4049\/jimmunol.179.7.4645","article-title":"A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling","volume":"179","author":"Rowland","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.07.017_bib29","doi-asserted-by":"crossref","first-page":"15392","DOI":"10.1074\/jbc.M909520199","article-title":"Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling","volume":"275","author":"Hostager","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.017_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.humimm.2023.08.142","article-title":"Decoding the contextual duality of CD40 functions","volume":"84","author":"Bandyopadhyay","year":"2023","journal-title":"Hum Immunol"},{"key":"10.1016\/j.apsb.2026.07.017_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm0598-627","article-title":"B cells inhibit induction of T cell-dependent tumor immunity","volume":"4","author":"Qin","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.07.017_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002371-200407000-00003","article-title":"Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes","volume":"27","author":"Perricone","year":"2004","journal-title":"J Immunother"},{"key":"10.1016\/j.apsb.2026.07.017_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.017_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-producing B cells promote the development of pancreatic neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.07.017_bib35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2019-319912","article-title":"Interleukin-1\u03b2-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression","volume":"70","author":"Takahashi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.07.017_bib36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.07.017_bib37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.017_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107709","article-title":"Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint","volume":"219","author":"Tang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.07.017_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/1074-7613(94)90073-6","article-title":"Mice deficient for the CD40 ligand","volume":"1","author":"Xu","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.017_bib41","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.4049\/jimmunol.177.11.7772","article-title":"Gut IgA class switch recombination in the absence of CD40 does not occur in the lamina propria and is independent of germinal centers","volume":"177","author":"Bergqvist","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.07.017_bib42","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1038\/s41467-019-12446-5","article-title":"CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.017_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44245","article-title":"The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets","volume":"8","author":"Koike","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.apsb.2026.07.017_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12943-023-01716-y","article-title":"CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer","volume":"22","author":"Xing","year":"2023","journal-title":"Mol Cancer"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:13:06Z","timestamp":1789600386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383526004545"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.017","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}